BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24161809)

  • 1. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
    Holst JJ
    Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
    Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
    Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
    Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor.
    Holst JJ; Madsbad S
    Surg Obes Relat Dis; 2016 Jul; 12(6):1236-42. PubMed ID: 27313194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes.
    Irwin N; Flatt PR
    Curr Opin Pharmacol; 2013 Dec; 13(6):989-95. PubMed ID: 24064397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism.
    Gribble FM; Reimann F
    Nat Rev Endocrinol; 2019 Apr; 15(4):226-237. PubMed ID: 30760847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut endocrine system as a coordinator of postprandial nutrient homoeostasis.
    Gribble FM
    Proc Nutr Soc; 2012 Nov; 71(4):456-62. PubMed ID: 22906726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric surgery - time to replace with GLP-1?
    Webb DL; Abrahamsson N; Sundbom M; Hellström PM
    Scand J Gastroenterol; 2017; 52(6-7):635-640. PubMed ID: 28276830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.
    Chaudhry S; Bernardes M; Harris PE; Maffei A
    Minerva Endocrinol; 2016 Mar; 41(1):43-56. PubMed ID: 26505694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Enteroendocrine System for Treatment of Obesity.
    Miedzybrodzka EL; Gribble FM; Reimann F
    Handb Exp Pharmacol; 2022; 274():487-513. PubMed ID: 35419620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery.
    Larraufie P; Roberts GP; McGavigan AK; Kay RG; Li J; Leiter A; Melvin A; Biggs EK; Ravn P; Davy K; Hornigold DC; Yeo GSH; Hardwick RH; Reimann F; Gribble FM
    Cell Rep; 2019 Feb; 26(6):1399-1408.e6. PubMed ID: 30726726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of the intestine in metabolic diseases.
    Bradley WD; Zwingelstein C; Rondinone CM
    Arch Physiol Biochem; 2011 Jul; 117(3):165-76. PubMed ID: 21671708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats.
    Oh TJ; Lee HJ; Cho YM
    Obes Surg; 2016 Jun; 26(6):1287-95. PubMed ID: 26334758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium.
    Gribble FM; Reimann F
    Annu Rev Physiol; 2016; 78():277-99. PubMed ID: 26442437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy.
    Papamargaritis D; le Roux CW; Sioka E; Koukoulis G; Tzovaras G; Zacharoulis D
    Surg Obes Relat Dis; 2013; 9(2):192-201. PubMed ID: 23183113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Dirksen C; Svane M
    Peptides; 2024 Jun; 176():171199. PubMed ID: 38552903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.